Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsuhiko Yanagisawa

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|May 25, 2005
GM1 ganglioside and the seeding of amyloid in Alzheimer's disease: endogenous seed for Alzheimer amyloidKatsuhiko Yanagisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 25, 2012
[Searching for biomarkers to diagnose dementia]Katsuhiko Yanagisawa
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|May 10, 2012
[Strategy and perspectives for development of Alzheimer disease-modifying drugs]Katsuhiko Yanagisawa
Biochimica Et Biophysica Acta|February 27, 2007
Role of gangliosides in Alzheimer's diseaseKatsuhiko Yanagisawa
Sub-Cellular Biochemistry|February 16, 2005
Cholesterol and amyloid beta fibrillogenesisKatsuhiko Yanagisawa
Journal of Neuroscience Research|October 23, 2002
Cholesterol and pathological processes in Alzheimer's diseaseKatsuhiko Yanagisawa
Brain and Nerve = Shinkei Kenkyu No Shinpo|August 6, 2011
[Newly approved drugs for Alzheimer disease: effectiveness and limitation]Katsuhiko Yanagisawa
Glycoconjugate Journal|April 24, 2015
GM1 ganglioside and Alzheimer's diseaseKatsuhiko Yanagisawa
Journal of Neurochemistry|January 11, 2011
Pathological significance of ganglioside clusters in Alzheimer's diseaseKatsuhiko Yanagisawa
Rinsho Shinkeigaku = Clinical Neurology|January 18, 2005
[Natural progression of Alzheimer's disease (AD): a perspective on possible therapies for advanced AD]Katsuhiko Yanagisawa
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|May 25, 2005
GM1 ganglioside and the seeding of amyloid in Alzheimer's disease: endogenous seed for Alzheimer amyloidKatsuhiko Yanagisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 25, 2012
[Searching for biomarkers to diagnose dementia]Katsuhiko Yanagisawa
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|May 10, 2012
[Strategy and perspectives for development of Alzheimer disease-modifying drugs]Katsuhiko Yanagisawa
Biochimica Et Biophysica Acta|February 27, 2007
Role of gangliosides in Alzheimer's diseaseKatsuhiko Yanagisawa
Sub-Cellular Biochemistry|February 16, 2005
Cholesterol and amyloid beta fibrillogenesisKatsuhiko Yanagisawa
Journal of Neuroscience Research|October 23, 2002
Cholesterol and pathological processes in Alzheimer's diseaseKatsuhiko Yanagisawa
Brain and Nerve = Shinkei Kenkyu No Shinpo|August 6, 2011
[Newly approved drugs for Alzheimer disease: effectiveness and limitation]Katsuhiko Yanagisawa
Glycoconjugate Journal|April 24, 2015
GM1 ganglioside and Alzheimer's diseaseKatsuhiko Yanagisawa
Journal of Neurochemistry|January 11, 2011
Pathological significance of ganglioside clusters in Alzheimer's diseaseKatsuhiko Yanagisawa
Rinsho Shinkeigaku = Clinical Neurology|January 18, 2005
[Natural progression of Alzheimer's disease (AD): a perspective on possible therapies for advanced AD]Katsuhiko Yanagisawa
Pageof 8